SCHEMBL632698

SCHEMBL632698

C[CH]c1ccc(C)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6920150 0.81 APLNR (0.43)
SCHEMBL1120460 0.81 APLNR (0.43)
SCHEMBL4303773 0.81 APLNR (0.43)
SCHEMBL7992438 0.78
SCHEMBL36005 0.78
SCHEMBL29396407 0.78
SCHEMBL3543859 0.78
SCHEMBL28760354 0.78 ELANE (0.38)
SCHEMBL15426962 0.78
SCHEMBL29411546 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024071216-A1 PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING SAME AS ACTIVE INGREDIENT 三井化学クロップ&ライフソリューション株式会社 2024-04-04 WO disclosed
WO-2023171783-A1 PYRAZOLE COMPOUND, AND NOXIOUS ORGANISM CONTROL AGENT CONTAINING SAME AS ACTIVE INGREDIENT 三井化学アグロ株式会社 2023-09-14 WO disclosed
US-10172854-B2 Compositions and methods for treating mitochondrial diseases BIOVISTA, INC. (US) 2019-01-08 US disclosed
US-20180110775-A1 COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL DISEASES BIOVISTA INC (US) 2018-04-26 US disclosed
US-9763939-B2 Compositions and methods for treating mitochondrial diseases BIOVISTA, INC. (US) 2017-09-19 US disclosed
US-20160213667-A1 COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL DISEASES BIOVISTA INC (US) 2016-07-28 US disclosed
EP-2375900-B1 METHODS FOR TREATING MULTIPLE SCLEROSIS USING TETRACYCLIC PYRAZINOINDOLES BIOVISTA INC (US) 2016-03-02 EP disclosed
US-20150111919-A1 COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS BIOVISTA INC (US) 2015-04-23 US disclosed
CN-102015634-B Pesticides DOW AGROSCIENCES LLC 2014-02-12 CN disclosed
WO-2013130422-A1 COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL DISEASES BIOVISTA, INC. (US) 2013-09-06 WO disclosed
US-20070225316-A1 Methods and compositions for treating schizophrenia MEDIVATION, INC. 2007-09-27 US disclosed
WO-2007087425-A1 METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA MEDIVATION NEUROLOGY,INC. (US) 2007-08-02 WO disclosed
US-20070117834-A1 Methods and compositions for treating Huntington's disease MEDIVATION NEUROLOGY, INC. 2007-05-24 US disclosed
US-20070117835-A1 Methods and compositions for treating Huntington's disease MEDIVATION NEUROLOGY, INC. 2007-05-24 US disclosed
WO-2007041697-A2 HYDROGENATED PYRIDO-INDOLE COMPOUNDS FOR THE TREATMENT OF HUNTINGTON ' S DISEASE MEDIVATION, INC. (GB) 2007-04-12 WO disclosed
US-20060223800-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDAZINES ADN ANTIDIABETICS GARLAND STEPHEN 2006-10-05 US disclosed
US-7109199-B2 Pyrazolopyridines and pyrazolopyridazines as antidiabetics SMITHKLINE BEECHAM CORPORATION (US) 2006-09-19 US disclosed
US-20040019052-A1 Pyrazolopyridines and pyrazolopyridazines as antidabetics SMITHKLINE BEECHAM P.L.C. (GB) 2004-01-29 US disclosed
EP-1319001-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDAZINES AS ANTIDIABETICS SMITHKLINE BEECHAM PLC (GB) 2003-06-18 EP disclosed
WO-2002024694-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDAZINES AS ANTIDIABETICS SMITHKLINE BEECHAM, P.L.C. (GB) 2002-03-28 WO disclosed